Middleton & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Middleton & Co's LLY Position: Q3 2026 in Review
Middleton & Co reduced its Eli Lilly (LLY) stake by 3.4% in Q3 2026, selling an estimated $520K and leaving 12,579 shares worth $14.6M. The position accounts for 1.54% of the portfolio, ranked #16.
Middleton & Co first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $15.6M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Middleton & Co held 12,579 shares of Eli Lilly worth $14.6M as of Q3 2026.
- Middleton & Co sold 441 Eli Lilly shares in Q3 2026, an estimated $520K.
- Eli Lilly made up 1.54% of Middleton & Co's portfolio in Q3 2026, its #16 holding.
- Middleton & Co first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- Middleton & Co's Eli Lilly position peaked at $15.6M in Q2 2026.
- 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Middleton & Co's 13F filing for Q3 2026, filed 23 Oct 2026.